How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QQX: Respiratory Specimen Nucleic Acid Sars-Cov-2 Test. View classification details, related manufacturers, 510(k) clearances, and recall records.
A device to detect and identify nucleic acid targets in respiratory specimens from SARS-CoV-2 that cause COVID-19 is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 nucleic acid targets in human clinical respiratory specimens from patients suspected of COVID-19 based on signs and symptoms of respiratory infections by their healthcare providers. The device is intended to aid in the diagnosis of COVID-19 in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.Explore microbiology records →
11 clearance records and 0 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Nov 1, 2021 to Feb 13, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QQX · Respiratory Specimen Nucleic Acid Sars-Cov-2 Test | 11 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Aptima SARS-CoV-2 AssayK243396 · QQX | Hologic, Inc. | 510(k) | Feb 13, 2025FDA decision date |
| cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 SystemsK240867 · QQX | Roche Molecular Systems, Inc. | 510(k) | Feb 11, 2025FDA decision date |
| Xpert® Xpress CoV-2 plus (XPRS-COV2-10)K242109 · QQX | Cepheid® | 510(k) | Jan 15, 2025FDA decision date |
| Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086)K241580 · QQX | Abbott Molecular | 510(k) | Dec 6, 2024FDA decision date |
| Applied Biosystems TaqPath COVID-19 Diagnostic PCR KitK233453 · QQX | Life Technologies Corporation | 510(k) | Jul 10, 2024FDA decision date |
| Xpert® Xpress CoV-2 plusK230440 · QQX | Cepheid® | 510(k) | Oct 13, 2023FDA decision date |
| cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 SystemsK231306 · QQX | Roche Molecular Systems, Inc. | 510(k) | Jun 1, 2023FDA decision date |
| cobas SARS-CoV-2 Qualitative for use on the cobas 6800/8800 SystemsK213804 · QQX | Roche Molecular Systems, Inc. | 510(k) | Oct 22, 2022FDA decision date |
| Simplexa COVID-19 DirectK212147 · QQX | Diasorin Molecular, LLC | 510(k) | Sep 13, 2022FDA decision date |
| BioFire COVID-19 Test 2K221460 · QQX | Biofire Defense, LLC | 510(k) | Jul 25, 2022FDA decision date |
| BioFire COVID-19 Test 2K211079 · QQX | Biofire Defense, LLC | 510(k) | Nov 1, 2021FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.